9.93
price up icon7.72%   0.73
 
loading
Xencor Inc stock is traded at $9.93, with a volume of 277.47K. It is up +7.72% in the last 24 hours and up +17.84% over the past month. Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$9.20
Open:
$9.38
24h Volume:
277.47K
Relative Volume:
0.33
Market Cap:
$710.28M
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-3.436
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+12.23%
1M Performance:
+17.84%
6M Performance:
-51.56%
1Y Performance:
-49.97%
1-Day Range:
Value
$9.21
$10.06
1-Week Range:
Value
$8.83
$10.06
52-Week Range:
Value
$7.16
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Name
Xencor Inc
Name
Phone
626-305-5900
Name
Address
465 N. HALSTEAD ST., PASADENA, CA
Name
Employee
250
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
XNCR's Discussions on Twitter

Compare XNCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XNCR
Xencor Inc
9.98 600.68M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
475.68 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.28 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.93 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.09 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.08 29.19B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-21-25 Initiated William Blair Outperform
Dec-12-24 Initiated Wells Fargo Overweight
Dec-02-24 Upgrade Piper Sandler Neutral → Overweight
Apr-16-24 Reiterated BTIG Research Buy
Feb-28-24 Downgrade Piper Sandler Overweight → Neutral
May-19-23 Initiated BofA Securities Buy
Dec-06-22 Initiated Cowen Outperform
Oct-13-22 Upgrade Raymond James Outperform → Strong Buy
Sep-21-22 Initiated JP Morgan Overweight
Jul-06-22 Resumed Canaccord Genuity Buy
Feb-11-22 Initiated BMO Capital Markets Outperform
Jan-21-22 Initiated SMBC Nikko Outperform
Dec-15-21 Initiated H.C. Wainwright Buy
Oct-15-21 Resumed BTIG Research Buy
Feb-24-21 Upgrade Raymond James Mkt Perform → Outperform
Mar-04-20 Initiated Barclays Underweight
Feb-25-20 Upgrade Guggenheim Neutral → Buy
Jan-30-20 Initiated RBC Capital Mkts Outperform
Nov-20-19 Resumed Guggenheim Neutral
Aug-07-19 Downgrade Guggenheim Buy → Neutral
Aug-07-19 Downgrade Raymond James Outperform → Mkt Perform
Jun-13-19 Initiated Mizuho Buy
Apr-12-19 Initiated Guggenheim Buy
Mar-27-19 Initiated Berenberg Buy
Mar-15-19 Initiated Raymond James Outperform
Sep-10-18 Resumed BTIG Research Buy
Mar-28-18 Resumed Leerink Partners Outperform
Mar-02-17 Initiated Instinet Neutral
Mar-02-17 Reiterated Wedbush Outperform
Oct-04-16 Initiated Piper Jaffray Overweight
Dec-22-15 Initiated Canaccord Genuity Buy
Aug-05-15 Reiterated MLV & Co Buy
Feb-12-15 Reiterated Oppenheimer Outperform
Jan-28-15 Reiterated MLV & Co Buy
Jul-11-14 Initiated Oppenheimer Outperform
View All

Xencor Inc Stock (XNCR) Latest News

pulisher
07:37 AM

What analysts say about Xencor Inc. stockConsistent high-yield stocks - Autocar Professional

07:37 AM
pulisher
06:08 AM

Is Xencor Inc. a good long term investmentFree AI-Backed Trading Signals - Autocar Professional

06:08 AM
pulisher
03:53 AM

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Arizona State Retirement System - Defense World

03:53 AM
pulisher
Jul 22, 2025

What drives Xencor Inc. stock priceFree Stock Market Query - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Xencor Inc. Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Xencor Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

Where are the Opportunities in (XNCR) - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 19, 2025

What risks could impact Xencor Inc. stock performanceVerified Return Tips - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Principal Financial Group Inc. Grows Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Xencor’s Phase 2 Study on Vudalimab in Prostate Cancer: Key Update and Market Impact - TipRanks

Jul 17, 2025
pulisher
Jul 16, 2025

[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 15, 2025

How Xencor Inc. stock performs during market volatilityFree Financial Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xencor Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jul 03, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 03, 2025
pulisher
Jul 01, 2025

Fed. Circ. Won't Revisit Jepson Claim Ruling In Xencor IP Case - Law360

Jul 01, 2025
pulisher
Jun 28, 2025

(XNCR) Investment Analysis - news.stocktradersdaily.com

Jun 28, 2025
pulisher
Jun 18, 2025

Closing Figures Unveiled: Xencor Inc (XNCR) Drop -8.18, Closes at 8.31 - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Rhumbline Advisers Has $1.74 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Xencor (NASDAQ:XNCR) Shares Down 5.7% on Insider Selling - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

(XNCR) On The My Stocks Page - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 17, 2025

Xencor director Gustafson sells shares worth $27,595 - Investing.com Australia

Jun 17, 2025
pulisher
Jun 16, 2025

Xencor director Montgomery sells shares worth $20,422 - Investing.com

Jun 16, 2025
pulisher
Jun 13, 2025

Xencor Holds Annual Stockholders Meeting on June 12 - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Xencor (NASDAQ:XNCR) Trading Up 6.3%Should You Buy? - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

USPTO Tells Fed. Circ. Not To Review Ruling In Xencor Case - Law360

Jun 12, 2025
pulisher
Jun 11, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jun 11, 2025
pulisher
Jun 10, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Sells 585,930 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com

Jun 05, 2025
pulisher
May 30, 2025

Xencor Inc (NASDAQ: XNCR) Jumps 2.45%: What Could Be On The Way Going Forward? - Stocksregister

May 30, 2025
pulisher
May 30, 2025

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside - DirectorsTalk Interviews

May 30, 2025
pulisher
May 28, 2025

Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress By Investing.com - Investing.com South Africa

May 28, 2025

Xencor Inc Stock (XNCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Xencor Inc Stock (XNCR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
GUSTAFSON KURT A
Director
Jun 16 '25
Sale
9.22
2,993
27,595
20,183
GORMAN KEVIN CHARLES
Director
Jun 16 '25
Sale
9.22
3,173
29,255
18,905
Feigal Ellen
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
RANIERI RICHARD J
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
$22.68
price up icon 3.81%
$35.90
price down icon 0.61%
$102.28
price down icon 0.64%
$27.73
price up icon 4.26%
$112.64
price up icon 1.24%
biotechnology ONC
$297.50
price up icon 0.52%
Cap:     |  Volume (24h):